ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,000 | -86.4% | 12,076 | -83.1% | 0.00% | – |
Q3 2021 | $154,000 | -36.1% | 71,468 | +3.8% | 0.00% | – |
Q2 2021 | $241,000 | -64.3% | 68,860 | +0.6% | 0.00% | – |
Q1 2021 | $675,000 | -32.7% | 68,455 | -26.0% | 0.00% | – |
Q4 2020 | $1,003,000 | -40.1% | 92,492 | -43.1% | 0.00% | -100.0% |
Q3 2020 | $1,674,000 | -19.1% | 162,438 | +63.9% | 0.00% | 0.0% |
Q2 2020 | $2,070,000 | +314.0% | 99,110 | +93.9% | 0.00% | – |
Q1 2020 | $500,000 | -52.8% | 51,119 | -44.4% | 0.00% | -100.0% |
Q4 2019 | $1,060,000 | +1506.1% | 91,947 | +653.8% | 0.00% | – |
Q3 2019 | $66,000 | -53.8% | 12,197 | +1.6% | 0.00% | – |
Q2 2019 | $143,000 | +120.0% | 12,009 | -3.6% | 0.00% | – |
Q1 2019 | $65,000 | +58.5% | 12,458 | -4.0% | 0.00% | – |
Q4 2018 | $41,000 | -50.0% | 12,974 | -16.7% | 0.00% | – |
Q2 2018 | $82,000 | +134.3% | 15,568 | +29.9% | 0.00% | – |
Q4 2016 | $35,000 | -41.7% | 11,982 | -18.2% | 0.00% | – |
Q3 2016 | $60,000 | -61.8% | 14,647 | -70.5% | 0.00% | – |
Q2 2016 | $157,000 | – | 49,696 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 178,654 | $652,000 | 0.48% |
EcoR1 Capital, LLC | 762,947 | $2,785,000 | 0.37% |
VHCP Management II, LLC | 280,000 | $1,022,000 | 0.28% |
MANGROVE PARTNERS IM, LLC | 413,838 | $1,511,000 | 0.26% |
Sessa Capital IM, L.P. | 638,712 | $2,331,000 | 0.26% |
683 Capital Management, LLC | 550,000 | $2,008,000 | 0.21% |
Rhenman & Partners Asset Management AB | 154,006 | $562,000 | 0.07% |
ELEMENT CAPITAL MANAGEMENT LLC | 35,346 | $129,000 | 0.05% |
Tekla Capital Management LLC | 300,078 | $1,095,000 | 0.04% |
Marquette Asset Management, LLC | 25,998 | $95,000 | 0.04% |